Hemostemix Management
Management criteria checks 3/4
Hemostemix's CEO is Thomas Smeenk, appointed in Dec 2019, has a tenure of 4.42 years. total yearly compensation is CA$308.00K, comprised of 67.5% salary and 32.5% bonuses, including company stock and options. directly owns 2.07% of the company’s shares, worth CA$63.02K. The average tenure of the management team and the board of directors is 3.4 years and 4.2 years respectively.
Key information
Thomas Smeenk
Chief executive officer
CA$308.0k
Total compensation
| CEO salary percentage | 67.5% |
| CEO tenure | 4.4yrs |
| CEO ownership | 2.1% |
| Management average tenure | 3.4yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CA$3m |
| Sep 30 2023 | n/a | n/a | -CA$3m |
| Jun 30 2023 | n/a | n/a | -CA$4m |
| Mar 31 2023 | n/a | n/a | -CA$5m |
| Dec 31 2022 | CA$308k | CA$208k | -CA$5m |
| Sep 30 2022 | n/a | n/a | -CA$7m |
| Jun 30 2022 | n/a | n/a | -CA$7m |
| Mar 31 2022 | n/a | n/a | -CA$7m |
| Dec 31 2021 | CA$224k | CA$224k | -CA$6m |
| Sep 30 2021 | n/a | n/a | -CA$7m |
| Jun 30 2021 | n/a | n/a | -CA$8m |
| Mar 31 2021 | n/a | n/a | -CA$8m |
| Dec 31 2020 | CA$277k | CA$277k | -CA$8m |
Compensation vs Market: Thomas's total compensation ($USD225.66K) is about average for companies of similar size in the Canadian market ($USD177.35K).
Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.
CEO
Thomas Smeenk (61 yo)
4.4yrs
Tenure
CA$308,000
Compensation
Mr. Thomas A. Smeenk, BA, is the Co-founder of Hemostemix Inc. and serves as its President and Director since December 9, 2019 and November 26, 2019 respectively. He serves as the Chief Executive Officer o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.4yrs | CA$308.00k | 2.07% CA$ 63.0k | |
| Interim Chief Financial Officer | 4.2yrs | CA$65.38k | no data | |
| Vice President of Operations | 2.3yrs | no data | no data | |
| Chief Medical Officer | 2.6yrs | no data | no data |
3.4yrs
Average Tenure
Experienced Management: HEM's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.5yrs | CA$308.00k | 2.07% CA$ 63.0k | |
| Independent Chairman | 4.2yrs | no data | 7% CA$ 213.4k | |
| Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Board of Advisors | 4.1yrs | no data | no data | |
| Independent Director | 4.1yrs | no data | 4.62% CA$ 140.9k | |
| Independent Director | 4.3yrs | no data | 0.65% CA$ 19.8k | |
| Member of Board of Advisors | 4.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.2yrs | no data | no data | |
| Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data |
4.2yrs
Average Tenure
67yo
Average Age
Experienced Board: HEM's board of directors are considered experienced (4.2 years average tenure).